Navigation Links
March of Dimes Awards $250,000 Prize to Scientist Who Discovered How to Reprogram Human Cells

New Method Bypasses Need to Obtain Stem Cells From Embryos

WHITE PLAINS, N.Y., Jan. 26 /PRNewswire-USNewswire/ -- The scientist who reprogrammed adult cells into embryonic-like stem cells has been chosen to receive the 2010 March of Dimes Prize in Developmental Biology.

Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease, San Francisco, and Kyoto University, Japan, will be honored with the 2010 March of Dimes Prize for his pioneering work that has fundamentally altered the field of developmental biology and will aid research into the prevention of birth defects.

Dr. Yamanaka has reprogrammed human skin cells into embryonic-like stem cells, which are pluripotent, meaning that they have the ability to develop into any kind of cell. The Yamanaka method eliminates the need to obtain stem cells from human embryos, a process that results in the destruction of the embryo.

"Dr. Yamanaka's remarkable achievement makes it possible to have virtually an unlimited number of pluripotent stem cells  that have the potential to be used  to correct or repair birth defects in children," said Michael Katz, MD, senior vice president for Research and Global Programs at the March of Dimes.

The March of Dimes Prize is a $250,000 cash award and a silver medal in the design of the Roosevelt dime, in honor of President Franklin Delano Roosevelt, who founded the March of Dimes. The Prize will be awarded to Dr. Yamanaka at a gala black-tie dinner and ceremony on May 3rd, 2010, in Vancouver, British Columbia, Canada, during the annual meeting of the Pediatric Academic Societies. Also on May 3, Dr. Yamanaka will deliver the Fifteenth Annual March of Dimes Prize Lectures at the Vancouver Convention Centre.

Dr. Yamanaka is the L.K. Whittier Foundation Investigator in Stem Cell Biology at the Gladstone Institute of Cardiovascular Disease and Professor of Anatomy at the University of California, San Francisco. He also is the director of the Center for iPS Cell Research and Application at the Institute for Integrated Cell-Material Sciences, and professor in the Department of Stem Cell Biology at the Institute for Frontier Medical Sciences, both at Kyoto University in Japan.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects.  The March of Dimes Foundation created the Prize as a tribute to Dr. Jonas Salk, who received Foundation support for his work to create a polio vaccine.

The March of Dimes is the leading nonprofit organization for pregnancy and baby health.  With chapters nationwide and its premier event, March for Babies®, the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality.  For the latest resources and information, visit or

SOURCE March of Dimes



SOURCE March of Dimes
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31, 2009 and the First Fiscal Quarter ended June 30, 2009 on September 1, 2009
2. The Crohns & Colitis Foundation of America and Shire Launch Virtual IBD March on the Hill to Increase Funding for Digestive Disease Research
3. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
4. Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009
5. The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health
6. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
7. New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando
8. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Tuesday, March 24, 2009
9. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
10. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
11. Milestone Scientific to Report 2008 Year-End Results on Tuesday, March 17, 2009
Post Your Comments:
(Date:11/27/2015)... 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), ... has closed the sale of its global contrast media ... Euronext) in a transaction valued at approximately $270 million. ... a total of approximately 1,000 employees spread across the ... Louis area. This entire workforce and the ...
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology:
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):